Impact of multitiered copayments on the use and cost of prescription drugs among medicare beneficiaries

Health Services Research

Volumn 43, Issue 2, 2008, Pages 478-495

  Gilman, Boyd H ^a   Kautter, John ^b  

^a MATHEMATICA POLICY RESEARCH   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Cost sharing; Medicare; Prescription drugs

Indexed keywords

DRUG; GENERIC DRUG; PRESCRIPTION DRUG; UNCLASSIFIED DRUG;

AGED; ARTICLE; CHRONIC DISEASE; DATA BASE; DRUG COST; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICARE; MONEY; MULTITIERED COPAYMENT; PRESCRIPTION; RETIREMENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEDUCTIBLES AND COINSURANCE; DRUG UTILIZATION; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH STATUS; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MEDICARE PART D; SEX FACTORS; UNITED STATES;

EID: 41149134763     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2007.00774.x     Document Type: Article

References (28)

1. Adamson, D. M., S. Chang L. G. Hansen. 2006. "Health Research Data for the Real World: The Marketscan Databases." White Paper, Research and Pharmaceutical Division, Thomson Medstat, January.
2. Briesacher, B., S. Kamal-Bahl, M. Hochberg, D. Orwig K. H. Kahler. 2004 Three-Tiered Copayment Drug Coverage and Use of Nonsteroidal Anti-Inflammatory Drugs Archives of Internal Medicine 164 (15) : 1679 84.
3. Congressional Budget Office. 2004 "A Detailed Description of CBO's Cost Estimate for the Medicare Prescription Drug Benefit." July.
4. Congressional Budget Office. 2005 "Letter to Honorable Joe Barton, Chairman, Committee on Energy and Commerce, U.S. House of Representatives." March 4.
5. Fairman, K. A., B. R. Motheral R. R. Henderson. 2003 Retrospective, Long-Term Follow-up Study of the Effect of a Three-Tiered Prescription Drug Copayment System on Pharmaceutical and Other Medical Utilization and Cost Clinical Therapeutics 25 (12) : 3147 61.
6. Federal Register. 2005 "Medicare Prescription Drug Benefit; Final Rule; 42 CFR Parts 400, 403, 411, 417, and 423." Volume 70, Number 18, January 28.
7. Gaynor, M., J. Li W. B. Vogt. 2006 "Is Drug Coverage a Free Lunch? Cross-Price Elasticities and the Design of Prescription Drug Benefits." NBER Working Paper No. 12758, December.
8. Gibson, T. B., T. L. Mark, K. A. McGuigan, K. Axelsen S. Wang. 2006 The Effects of Prescription Drug Copayments on Statin Adherence American Journal of Managed Care 12 (9) : 509 17.
9. Gibson, T. B., C. G. McLaughlin D. G. Smith. 2005a A Copayment Increase for Prescription Drugs: The Long-Term and Short-Term Effects on Use and Expenditures Inquiry 42 (3) : 293 310.
10. Gibson, T. B., R. J. Ozminkowski R. Z. Goetzel. 2005b The Effects of Prescription Drug Cost Sharing: A Review of the Evidence American Journal of Managed Care 11 (11) : 730 40.
11. Gilman, B. H. J. Kautter. 2007 Consumer Response to Dual Incentives under Multi-Tiered Prescription Drug Formularies American Journal of Managed Care 13 (6, pt. 2) : 353 9.
12. Gleason, P. P., B. W. Gunderson K. R. Gericke. 2005 Are Incentive-Based Formularies Inversely Associated with Drug Utilization in Managed Care? Annals of Pharmacotherapies 39 (2) : 339 45.
13. Goldman, D. P., G. F. Joyce, J. J. Escarce, P. E. Pace, M. D. Solomon, M. Laouri, P. B. Landsman S. M. Teutsch. 2004 Pharmacy Benefits and the Use of Drugs by the Chronically Ill Journal of the American Medical Association 291 (19) : 2344 50.
14. Goldman, D. P., G. F. Joyce J. D. Malkin. 2002 "The Costs of a Medicare Prescription Drug Benefit: A Comparison of Alternatives." Rand MR-1529.0-NIA, January.
15. Hoadley, J. 2005. "The Effect of Formularies and Other Cost Management Tools on Access to Medications: An Analysis of the MMA and the Final Rule." Kaiser Family Foundation. March.
16. Huskamp, H. A., P. A. Deverka, A. M. Epstein, R. S. Epstein, K. A. McGuigan R. G. Frank. 2003 The Effect of Incentive-Based Formularies on Prescription Drug Utilization and Spending New England Journal of Medicine 349 (23) : 2224 32.
17. Huskamp, H. A., R. G. Frank, K. A. McGuigan Y. Zhang. 2005 The Impact of a Three-Tier Formulary on Demand Response for Prescription Drugs Journal of Economics and Management Strategy 14 (3) : 729 53.
18. Joyce, G. F., J. J. Escarce, M. D. Solomon G. P. Goldman. 2002 Employer Drug Benefit Plans and Spending on Prescription Drugs Journal of the American Medical Association 288 (14) : 1733 9.
19. Kamal-Bahl, S. B. Briesacher. 2004 How Do Incentive-Based Formularies Influence Drug Selection and Spending for Hypertension? Health Affairs 23 (1) : 227 36.
20. Lillard, L. A., J. Rogowski R. Kington. 1999 Insurance Coverage for Prescription Drugs: Effects on Use and Expenditures in the Medicare Population Medical Care 37 (9) : 926 36.
21. Medicare Payment Advisory Commission. 2006 "Report to Congress: Increasing the Value of Medicare." June.
22. Motheral, B. R. K. A. Fairman. 2001 Effect of Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization Medical Care 39 (12) : 1293 304.
23. Nair, K. V., P. Wolfe, R. J. Valuck, M. M. McCollum, J. M. Ganther S. J. Lewis. 2003 Effects of a Three-Tier Pharmacy Benefit Design on the Prescription Purchasing Behavior of Individuals with Chronic Diseases Journal of Managed Care Pharmacy 9 (2) : 123 33.
24. Pauly, M. V. 2004 Medicare Drug Coverage and Moral Hazard Health Affairs 23 (1) : 113 22.
25. Pope, G. C., J. Kautter, R. P. Ellis, A. S. Ash, J. Z. Ayanian, L. I. Iezzoni, M. J. Ingber, J. M. Levy J. Robst. 2004 Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model Health Care Financing Review 25 (4) : 119 41.
26. Rector, T. S., M. D. Finch, P. M. Danzon, M. V. Pauly B. S. Manda. 2003 Effect of Tiered Prescription Copayment on the Use of Preferred Brand Medications Medical Care 41 (3) : 398 406.
27. Roblin, D. W., R. Platt, M. J. Goodman, J. Hsu, W. W. Nelson, D. H. Smith, S. Andrade S. B. Soumerai. 2005 Effect of Increased Cost Sharing on Oral Hypoglycemic Use in Five Managed Care Organizations: How Much Is Too Much? Medical Care 43 (10) : 951 9.
28. Thomas, C. P., S. S. Wallack, S. Lee G. A. Ritter. 2002 Impact of Health Plan Design and Management on Retirees' Prescription Drug Use and Spending, 2001 Health Affairs (Web Exclusive) : W408 19.